drugset / Trial / NCT05991232
Repeated Neurocognitive Measurements in Depressed Patients
NaSingle-groupOpen-labelBasic science
Summary
In this project, we will A) track the functioning of a collection of potential neurobiological targets for depression over time, B) examine how fluctuations in the functioning of those targets relates to real-world functioning, and C) in a subset of the sample, determine how the functioning in those targets is altered by a single dose of ketamine.
Timeline
- Start
- 2025-05-01
- Primary completion
- 2028-04
- Completion
- 2029-04
Outcome
Outcome not reported
Stopped (Enrollment): “This study never started enrollment at this site. Delays in establishing the infrastructure for this project resulted in the funds no longer being available at this time. Should additional funds be secured, a separate study will be registered here.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.5 mg/kg | Intravenous |